NQF launches task force on the next generation of quality

Mar 25, 2019 - 02:38 PM
high quality care

In partnership with the AHA and other national health care leaders, the National Quality Forum today launched a task force to identify opportunities to drive and optimize high-value, person-centered care for every patient by 2030. The panel expects to issue recommendations by year-end based on input from top experts and pioneering health care leaders. “Health care quality efforts to this point have successfully embedded the expectation of safe, high quality care,” said NQF President and CEO Shantanu Agrawal, task force co-chair. “Now is the time to ensure the next generation of quality achieves significant improvements in value, driven by consumer and community goals.” In addition to AHA, partners in the initiative include Kaiser Permanente, Geisinger, Intermountain Healthcare and HCA Healthcare.

Related News Articles

Headline
CDC issues advisory to healthcare providers on cyclosporiasis cases
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…
Headline
Cyclosporiasis continues to spread across country
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
FDA issues alert for certain Medline convenience kits 
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
FDA recalls certain first aid kits with TRUE METRIX blood glucose devices 
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
AHA podcast discusses hantavirus, Ebola outbreaks and hospital readiness 
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…